Viewing Study NCT03012165



Ignite Creation Date: 2024-05-06 @ 9:34 AM
Last Modification Date: 2024-10-26 @ 12:16 PM
Study NCT ID: NCT03012165
Status: COMPLETED
Last Update Posted: 2023-01-09
First Post: 2016-12-14

Brief Title: A Study of ADX-102 in Subjects With Allergic Conjunctivitis
Sponsor: Aldeyra Therapeutics Inc
Organization: Aldeyra Therapeutics Inc

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2022-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A Multi-Center Double-Masked Randomized Vehicle-Controlled Phase 2b Evaluation of the Onset and Duration of ADX-102 Ophthalmic Drops 05 and 01 Compared to Vehicle of ADX-102 Ophthalmic Drops in the Conjunctival Allergen Challenge Ora-CAC Model of Acute Allergic Conjunctivitis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None